Caidya was engaged to provide full-service clinical research service for a pivotal Phase III trial conducted across China. Conducted under multiple stakeholders with divergent priorities, this study sought to enroll over 500 participants across approximately 40 sites, requiring meticulous coordination and stringent oversight.
Back to Resource Center